Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-Y Chien

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Diabetes, Obesity & Metabolism|January 22, 2011
A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetesP Barrington, J Y Chien, H D H Showalter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 16, 2010
Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatmentJ-Y Chien, R-M Huang, J-Y Wang, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazidJ Y Chien, R M Peter, C M Nolan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 4, 2020
Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung diseaseS-W Pan, C-C Shu, J-Y Feng, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 30, 2026
Lower FEV<sub>1</sub> and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasisW-F Ou, C-H Chu, C-C Sheu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Diabetes, Obesity & Metabolism|January 22, 2011
A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetesP Barrington, J Y Chien, H D H Showalter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 16, 2010
Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatmentJ-Y Chien, R-M Huang, J-Y Wang, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazidJ Y Chien, R M Peter, C M Nolan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 4, 2020
Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung diseaseS-W Pan, C-C Shu, J-Y Feng, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 30, 2026
Lower FEV<sub>1</sub> and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasisW-F Ou, C-H Chu, C-C Sheu, et al.
Pageof 2